Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma

Figure 1 Genetic alternation of FABP family members in various cancer types. A-B: Genetic alternation of each FABP family member (FABP1, FABP2, FABP3, FABP4, FABP5, FABP6, FABP7, PMP2, FABP9 and FABP12) in pan-cancer types (70655 samples from 217 non-redundant studies) (A) and in various liver cancer subtypes (1829 samples from eleven studies) (B) using The Cancer Genome Atlas datasets. The mutation frequency for each FABP gene was shown next to the gene name; C: Co-occurrence of genetic alternation of the gene loci of FABP family members in liver cancer.